Clonidine is available under several brand names, with Catapres being a prominent one [1]. It is also marketed as Dixarit and Kapvay [1].
What is Clonidine used for?
Clonidine is primarily prescribed to treat high blood pressure (hypertension) [2]. It can also be used to manage attention deficit hyperactivity disorder (ADHD), particularly the Kapvay formulation [3]. Additionally, Catapres is indicated for managing withdrawal symptoms from certain substances and for certain pain management applications [2].
How does Clonidine work?
Clonidine is an alpha-2 adrenergic agonist. It works by stimulating alpha-2 receptors in the brain, which decreases the sympathetic outflow from the central nervous system. This leads to a reduction in heart rate, blood pressure, and peripheral vascular resistance [2].
When does Clonidine patent exclusivity expire?
Patent exclusivity for clonidine-containing medications can vary. For instance, the patent for extended-release Kapvay was set to expire in 2023, according to information from DrugPatentWatch.com [4]. It is important to note that patents can be complex and may involve multiple layers of protection and potential litigation [4].
Can generic versions of Clonidine be made?
Once brand-name drug patents expire, generic manufacturers can typically produce bioequivalent versions of the medication, provided they meet regulatory standards [4]. This has occurred for various clonidine formulations, leading to the availability of generic clonidine tablets and patches [1, 2].
What are the potential side effects of Clonidine?
Common side effects associated with clonidine include drowsiness, dizziness, dry mouth, and constipation [5]. Some individuals may experience rebound hypertension if the medication is stopped abruptly [5].
How is Clonidine administered?
Clonidine is available in various forms, including oral tablets, extended-release tablets, and transdermal patches [2, 3]. The specific formulation and administration method depend on the intended use and prescribed dosage.